Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease: Evidence of impaired glutamatergic neurotransmission?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Neurology

• Publication date

  2003-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.10600PMID 12783437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer’s disease

  2004cited by this paper
• Ketamine Increases Human Motor Cortex Excitability to Transcranial Magnetic Stimulation

  2003cited by this paper
• Motor cortex excitability in Alzheimer's disease: A transcranial magnetic stimulation study

  2003cited by this paper
• Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms

  2002cited by this paper
• Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices.

  2002cited by this paper
• Differential Regulation of Glutamate Receptors in Alzheimer’s Disease

  2002cited by this paper
• Selective muscarinic regulation of functional glutamatergic Schaffer collateral synapses in rat CA1 pyramidal neurons

  2002cited by this paper
• Large‐scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′nuclease (Taqman®) assay

  2002cited by this paper
• Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation

  2002cited by this paper
• Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

  2001cited by this paper
• Health: Endothelin-1 synthesis reduced by red wine

  2001cited by this paper
• Increased Endothelin-1 Plasma Levels in Patients With Multiple Sclerosis

  2001cited by this paper
• Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye.

  2001cited by this paper
• Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex

  2000cited by this paper
• Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis.

  2000cited by this paper
• Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

  1999cited by this paper
• Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease.

  1997influential reference
• Parkinson's Disease Society Brain Bank, London: overview and research.

  1993cited by this paper

• Neurophysiological signatures of default mode network dysfunction and cognitive decline in Alzheimer’s disease

  2025cites this paper
• Neurophysiological signatures of default mode network dysfunction and cognitive decline in Alzheimer’s disease

  2024cites this paper
• Cortical hyperexcitability and plasticity in Alzheimer’s disease: developments in understanding and management

  2022cites this paper
• Transcranial Magnetic Stimulation as a Diagnostic and Therapeutic Tool in Various Types of Dementia

  2021cites this paper
• Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum

  2021cites this paper
• Repetitive Transcranial Magnetic Stimulation Improves Mild Cognitive Impairment Associated with Alzheimer’s Disease in Mice by Modulating the miR-567/NEUROD2/PSD95 Axis

  2021cites this paper
• Increased Signal Delays and Unaltered Synaptic Input Pattern Recognition in Layer III Neocortical Pyramidal Neurons of the rTg4510 Mouse Model of Tauopathy: A Computer Simulation Study With Passive Membrane

  2021cites this paper
• Administration of rTMS Alleviates Stroke-Induced Cognitive Deficits by Modulating miR-409-3p/CTRP3/AMPK/Sirt1 Axis

  2021cites this paper
• Temporal Lobe Epilepsy and Alzheimer’s Disease: From Preclinical to Clinical Evidence of a Strong Association

  2021cites this paper
• Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic

  2020cites this paper
• Estudio de la influencia de la actividad física y la fatiga en personas con esclerosis múltiple

  2020cites this paper
• Evaluation and Treatment of Vascular Cognitive Impairment by Transcranial Magnetic Stimulation

  2020cites this paper
• Changes in recruitment of motor cortex excitation and inhibition in patients with drug-induced tardive syndromes.

  2019cites this paper
• Association of Brain-derived Neurotrophic Factor (BDNF) Gene SNPs G196A and C270T with Parkinson’s disease: A Meta- Analysis

  2018cites this paper
• Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke

  2018cites this paper
• BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders

  2018cites this paper
• The Role of Cognitive Reserve in Alzheimer’s Disease and Aging: A Multi-Modal Imaging Review

  2018cites this paper
• Transcranial Magnetic Stimulation and Cognitive Impairment

  2018cites this paper
• Transcranial magnetic stimulation in myoclonus of different aetiologies.

  2018cites this paper
• Transcranial magnetic stimulation studies in complex regional pain syndrome type I: A review

  2018cites this paper
• Association of BDNF Val66MET Polymorphism With Parkinson's Disease and Depression and Anxiety Symptoms.

  2017cites this paper
• The discovery of the Flammer syndrome: a historical and personal perspective

  2017cites this paper
• BDNF in the Aged Brain: Translational Implications for Parkinson's Disease.

  2017cites this paper
• A Study of Cortical Excitability, Central Motor Conduction, and Cortical Inhibition Using Single Pulse Transcranial Magnetic Stimulation in Patients with Early Frontotemporal and Alzheimer's Dementia

  2016cites this paper
• Oxidative stress in the trabecular meshwork (Review).

  2016cites this paper
• A Novel Form of Compensation in the Tg2576 Amyloid Mouse Model of Alzheimer’s Disease

  2016cites this paper
• Altered Cortical Synaptic Plasticity in Response to 5-Hz Repetitive Transcranial Magnetic Stimulation as a New Electrophysiological Finding in Amnestic Mild Cognitive Impairment Converting to Alzheimer’s Disease: Results from a 4-year Prospective Cohort Study

  2016cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease

  2016cites this paper
• Abnormal short-latency synaptic plasticity in the motor cortex of subjects with Becker muscular dystrophy: a rTMS study.

  2016cites this paper
• Neurophysiological features of motor cortex excitability and plasticity in Subcortical Ischemic Vascular Dementia: a TMS mapping study.

  2015cites this paper
• Meta-Analysis Study on the Role of Bone-Derived Neurotrophic Factor Val66Met Polymorphism in Parkinson's Disease

  2015cites this paper
• Non-Invasive Brain Stimulation Techniques May Improve Language Recovery in Stroke Patients Modulating Neural Plasticity

  2014cites this paper
• BDNF 196 G/A and 270 C/T Polymorphisms and Susceptibility to Parkinson's Disease: A Meta-Analysis

  2014influential citation
• The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.

  2014cites this paper
• Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson’s Disease

  2014cites this paper
• microPIR2: a comprehensive database for human–mouse comparative study of microRNA–promoter interactions

  2014cites this paper
• Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease

  2014cites this paper
• Apraxia and Motor Dysfunction in Corticobasal Syndrome

  2014cites this paper
• BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.

  2014cites this paper
• The primary vascular dysregulation syndrome: implications for eye diseases

  2013cites this paper
• [Value of non-IOP lowering therapy for glaucoma].

  2013cites this paper
• Clinical neurophysiology of brain plasticity in aging brain.

  2013cites this paper
• SNCA: Major genetic modifier of age at onset of Parkinson's disease

  2013cites this paper
• Dementia.

  2013cites this paper
• Association between the BDNF G196A and C270T polymorphisms and Parkinson's disease: a meta-analysis

  2013cites this paper
• No Association between Brain-Derived Neurotrophic Factor G196A Polymorphism and Clinical Features of Parkinson's Disease

  2013cites this paper
• Non-Invasive Brain Stimulation Techniques May Improve Language Recovery in Stroke Patients Modulating Neural

  2013cites this paper
• The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients

  2013cites this paper
• Transcranial direct current stimulation modulates motor responses evoked by repetitive transcranial magnetic stimulation

  2012cites this paper
• Synaptic Plasticity in Neurodegenerative Diseases Evaluated and Modulated by In Vivo Neurophysiological Techniques

  2012cites this paper
• Altered Parietal-Motor Connections in Alzheimer's Disease Patients

  2012cites this paper
• Therapeutic Potential of Neurotrophic Factors in Neurodegenerative Diseases

  2012cites this paper
• Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation.

  2012cites this paper
• Transcranial magnetic stimulation in Alzheimer’s disease: a neurophysiological marker of cortical hyperexcitability

  2011cites this paper
• Brain Derived Neurotrophic Factor (BDNF) Expression Is Regulated by MicroRNAs miR-26a and miR-26b Allele-Specific Binding

  2011cites this paper
• Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection

  2011cites this paper
• Transcranial Magnetic Stimulation Studies in Alzheimer's Disease

  2011cites this paper
• Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation follow-up study.

  2011cites this paper
• 19. Dopamine Dysregulation Syndrome

  2011cites this paper
• TMS and TMS-EEG studies on the excitability, connectivity and plasticity of the human motor cortex

  2011cites this paper
• Classifying risk factors for dyskinesia in Parkinson's disease.

  2010cites this paper
• Molecular mechanisms of pathogenesis of Parkinson's disease.

  2010cites this paper
• Genotyping the BDNF rs6265 (val66met) polymorphism by one-step amplified refractory mutation system PCR

  2010cites this paper
• Targeted preventive measures and advanced approaches in personalised treatment of glaucoma neuropathy

  2010cites this paper
• The role of endothelin in the pathophysiology of glaucoma

  2010cites this paper
• Neural substrates of insulin-mediated memory facilitation in early Alzheimer's disease; the impact of the apolipoprotein E-epsilon-4 allele on hippocampal insulin responses

  2009cites this paper
• The Benefits of Calorie Restriction and Calorie Restriction Mimetics as Related to the Eye.

  2009cites this paper
• Dissociating β-Amyloid from α7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes α7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain

  2009cites this paper
• l-dopa modulates motor cortex excitability in Alzheimer’s disease patients

  2008cites this paper
• The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome

  2008cites this paper
• The potential value of natural antioxidative treatment in glaucoma.

  2008cites this paper
• BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation

  2008cites this paper
• Dopamine Dysregulation Syndrome

  2008cites this paper
• BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson’s disease

  2008cites this paper
• In vivo functional evaluation of central cholinergic circuits in vascular dementia.

  2008cites this paper
• Genetic Epidemiology of Parkinson disease

  2008cites this paper
• A novel perspective on natural therapeutic approaches in glaucoma therapy

  2007cites this paper
• Is there more to glaucoma treatment than lowering IOP?

  2007cites this paper
• Microfluorimetry defines early axonal damage in a rat model of optic neuritis: a novel method targeting early CNS autoimmunity.

  2007cites this paper
• Clinical neurophysiology of aging brain: from normal aging to neurodegeneration.

  2007cites this paper
• Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese parkinson's disease

  2007influential citation
• Evaluation der Minimalen Alveolären Konzentration von Isofluran bei zwei transgenen Mausmodellen für die Alzheimer Krankheit

  2007cites this paper
• Cortical plasticity in Alzheimer's disease in humans and rodents.

  2007cites this paper
• BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups.

  2007cites this paper
• Functional evaluation of cerebral cortex in dementia with Lewy bodies

  2007cites this paper
• Altered response to rTMS in patients with Alzheimer's disease.

  2006cites this paper
• Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease

  2006cites this paper
• Molecular genetics of Parkinson’s disease

  2006cites this paper
• The BDNF-Val66Met polymorphism: implications for susceptibility to multiple sclerosis and severity of disease.

  2005cites this paper
• The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis

  2005influential citation
• New ideas on the origin of L-dopa-induced dyskinesias: age, genes and neural plasticity.

  2005cites this paper
• Association study between brain‐derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan

  2005cites this paper
• Reliability of spatiotemporal gait outcome measures in Huntington's disease

  2005cites this paper
• Brain‐derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy

  2005cites this paper
• Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.

  2005cites this paper
• Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease

  2005cites this paper
• Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson's disease.

  2004cites this paper
• Dementia in Parkinson’s disease – causes and treatment Review: Dementia in Parkinson’s disease: cause and treatment (pp 399–404)

  2004cites this paper
• Genetic contributions to Parkinson's disease.

  2004cites this paper